MMED vs STVN: stock comparison and AI forecast
Minimed Group, Inc. (MMED) and Stevanato Group S.P.A. (STVN) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
MMED Minimed Group, Inc.
- Price
- $18.90 +59.2% · 6M
- Market Cap
- $5.32B
- P/E Ratio
- –
- Size
- mid-cap
- AI Forecast
STVN Stevanato Group S.P.A.
- Price
- $19.38 +14.0% · 6M
- Market Cap
- $5.29B
- P/E Ratio
- 8.4x
- Size
- mid-cap
- AI Forecast
- NO CURRENT FORECAST
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- MMED and STVN have similar market capitalizations ($5.32B and $5.29B).
- Over the last six months MMED returned +59.2% and STVN +14.0%.
- STVN carries 0.71 times debt per unit of equity, against 0.30 times for MMED.
- Both companies share the SEC industry classification Surgical & Medical Instruments & Apparatus.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | MMED | STVN |
|---|---|---|
| Market Cap | $5.32B | $5.29B |
| P/E Ratio | – | 8.43x |
| P/B Ratio | 1.47x | – |
| EPS | – | $2.30 |
| Book Value/Share | $12.87 | – |
| Revenue/Share | – | $18.09 |
| FCF/Share | – | $-2.42 |
Profitability & Margins
| Metric | MMED | STVN |
|---|---|---|
| ROE | – | 36.7% |
| ROA | – | 21.5% |
| ROIC | – | 37.5% |
| Gross Margin | – | 30.0% |
| Operating Margin | – | 17.3% |
| Net Margin | – | 12.5% |
| EBT Margin | – | 16.7% |
| Tax Rate | – | 24.8% |
Financial Health
| Metric | MMED | STVN |
|---|---|---|
| Current Ratio | 1.81x | 1.76x |
| Quick Ratio | 1.36x | 1.26x |
| D/E Ratio | 0.30x | 0.71x |
| Financial Leverage | 1.30x | 1.71x |
| Working Capital | $635M | $479M |
Cash Flow
| Metric | MMED | STVN |
|---|---|---|
| Operating Cash Flow | – | $737M |
| Free Cash Flow | – | -$662M |
| Capital Spending | – | -$1.40B |
| FCF/Sales | – | -13.4% |
| CapEx/Sales | – | 28.3% |
Operational Efficiency
| Metric | MMED | STVN |
|---|---|---|
| Asset Turnover | – | 1.71x |
| Inventory Turnover | – | 11.4x |
| Fixed Assets Turnover | – | 3.1x |
| Days Inventory | – | 32 days |
| Payables Period | – | 41 days |
Income Statement
| Metric | MMED | STVN |
|---|---|---|
| Total Revenue | – | $4.94B |
| Operating Income | – | $853M |
| Net Income | – | $619M |
| R&D Expense | – | $144M |
| Cost of Goods Sold | – | $3.46B |
Dividend & Shareholder Information
| Metric | MMED | STVN |
|---|---|---|
| Shares Outstanding | 281M | 273M |
MMED vs STVN: stock comparison and AI forecast
Which is bigger, MMED or STVN?
MMED and STVN have similar market capitalizations ($5.32B and $5.29B).
Which stock performed better over the last six months, MMED or STVN?
Over the last six months MMED returned +59.2% and STVN +14.0%.
Which one does Intratio's AI model rank higher, MMED or STVN?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.